L
2291
vs
H
Hang Seng (Hong Kong)
Over the past 12 months, Lepu Scientech Medical Technology Shanghai Co Ltd has underperformed Hang Seng (Hong Kong), delivering a return of -20% compared to the Hang Seng (Hong Kong)'s +8% growth.
Stocks Performance
2291 vs Hang Seng (Hong Kong)
Performance Gap
2291 vs Hang Seng (Hong Kong)
Performance By Year
2291 vs Hang Seng (Hong Kong)
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Lepu Scientech Medical Technology Shanghai Co Ltd
Glance View
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. operates as an investment holding company. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2022-11-08. The firm operates primarily through two segments. The Occluder Business segment is mainly engaged in the research and development and sales of a series of interventional treatment series occluders for defective congenital heart disease. The Heart Valve Business segment is mainly engaged in the research and development of heart valve medical devices. The firm operates primarily in the domestic market.
